Total Funding
67
56
Total FundingSeries A raised
Growth Score
-11 pts
Heat Score
-4 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
35160
VLP is a biotech company with a mission to address unmet medical needs worldwide and expand the frontiers of vaccine treatment.
Kei Tolliver: Co-Founder
Jonathan F. Smith: Chief Scientific OfficerPast Role: PaxVax, CSO
About the Company
VLP Therapeutics, LLC (VLP) was established in 2012 by seasoned biopharmaceutical veterans with mission to develop innovative medical treatment which transforms traditional vaccine and targeted antibody therapies to address global unmet medical needs. Its vision is to combat the 21st century global public health problems through revolutionary next
generation i-αVLP (inserted alpha VLP) Technology. The company is headquartered in Gaithersburg, Maryland
Women Founded
